您的位置: 首页 > 农业专利 > 详情页

"HUMAN MONOCLONAL ANTIBODY ISOLATED, COMPOSITION, ASSOCIATED ANTIBODY-MOLLECLE PARTNERSHIP, IMMUNOCOUGHTED, ISOLATED NUCLEIC ACID MOLECULES, EXPRESSION VECTOR, HOSPEDIC CELL FOR PREPARING A CDT FOR THE PREPARATION OF A CD22 AND METHOD FOR TREATING INFLAMMATORY DISEASE OR SELF-IMMUNEING AN INDIVIDUAL "
专利权人:
MEDAREX; INC.
发明人:
DAVID JOHN KING,ALISON WITTE,HEIDI N. LEBLANC,RICHARD THEOLIS,ASNA MASOOD,MARK YAMANAKA,SARA R. DWIGGINS,TIM SPROUL,CHETANA RAO-NAIK,DAVID PASSMORE,KRISTOPHER TOY,DAWN M TANAMACHI,KYRA D. ZENS
申请号:
BRPI0717902
公开号:
BRPI0717902A2
申请日:
2007.11.30
申请国别(地区):
BR
年份:
2013
代理人:
摘要:
The present disclosure provides isolated monoclonal antibodies that specifically bind to CD22 with high affinity, particularly human monoclonal antibodies. Nucleic acid molecules encoding the antibodies of this disclosure, expression vectors, host cells and methods for expressing the antibodies of this disclosure are also provided. Antibody-partner molecule conjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of this disclosure are also provided. This disclosure also provides methods for detecting CD22, as well as methods for treating various cancers and inflammatory and autoimmune disorders using an anti-CD22 antibody of this disclosure.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充